← Open Payments lookup

DHIREN PATEL: Open Payments

NPI 1528078466 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,958 in 167 payments from 22 companies in 2025. Trend: 2023 $3,143 · 2024 $4,132 · 2025 $2,958

Food & beverage: $2,958
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$449
Otsuka America Pharmaceutical, Inc.18$370
Corium, LLC20$324
Janssen Pharmaceuticals, Inc14$279
Axsome Therapeutics, Inc.12$209
Lundbeck LLC9$198
Tris Pharma Inc16$174
Supernus Pharmaceuticals, Inc.16$172
Almatica Pharma LLC9$151
Collegium Pharmaceutical, Inc.6$93

Products named: REXULTI, CAPLYTA, Azstarys, SPRAVATO, Auvelity, Dyanavel XR, Qelbree, LOREEV XR.

Industry payments across TX — which companies pay providers there.